Geratherm Medical Balance Sheet Health
Financial Health criteria checks 3/6
Geratherm Medical has a total shareholder equity of €21.4M and total debt of €6.6M, which brings its debt-to-equity ratio to 30.8%. Its total assets and total liabilities are €33.7M and €12.3M respectively.
Key information
30.8%
Debt to equity ratio
€6.57m
Debt
| Interest coverage ratio | n/a |
| Cash | €6.33m |
| Equity | €21.37m |
| Total liabilities | €12.29m |
| Total assets | €33.65m |
Recent financial health updates
Is Geratherm Medical (ETR:GME) A Risky Investment?
Mar 02
Is Geratherm Medical (ETR:GME) A Risky Investment?
Mar 01We Think Geratherm Medical (ETR:GME) Can Stay On Top Of Its Debt
Nov 29
Recent updates
Geratherm Medical AG (ETR:GME) Stock Catapults 28% Though Its Price And Business Still Lag The Industry
Dec 13Investors Don't See Light At End Of Geratherm Medical AG's (ETR:GME) Tunnel And Push Stock Down 26%
Oct 16The Market Lifts Geratherm Medical AG (ETR:GME) Shares 28% But It Can Do More
Aug 21We Think Geratherm Medical's (ETR:GME) Solid Earnings Are Understated
Jun 27Geratherm Medical (ETR:GME) Is Reducing Its Dividend To €0.12
Apr 10Is Geratherm Medical (ETR:GME) A Risky Investment?
Mar 02Geratherm Medical (ETR:GME) Has Some Way To Go To Become A Multi-Bagger
May 08Is Geratherm Medical AG's (ETR:GME) 2.1% Dividend Sustainable?
Apr 19Is Geratherm Medical (ETR:GME) A Risky Investment?
Mar 01Returns On Capital Tell Us A Lot About Geratherm Medical (ETR:GME)
Jan 22Consider This Before Buying Geratherm Medical AG (ETR:GME) For The 2.3% Dividend
Jan 04Update: Geratherm Medical (ETR:GME) Stock Gained 22% In The Last Year
Dec 17We Think Geratherm Medical (ETR:GME) Can Stay On Top Of Its Debt
Nov 29Financial Position Analysis
Short Term Liabilities: GME's short term assets (€19.2M) exceed its short term liabilities (€870.3K).
Long Term Liabilities: GME's short term assets (€19.2M) exceed its long term liabilities (€11.4M).
Debt to Equity History and Analysis
Debt Level: GME's net debt to equity ratio (1.1%) is considered satisfactory.
Reducing Debt: GME's debt to equity ratio has increased from 27.8% to 30.8% over the past 5 years.
Debt Coverage: GME's debt is not well covered by operating cash flow (0.5%).
Interest Coverage: Insufficient data to determine if GME's interest payments on its debt are well covered by EBIT.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 04:14 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Geratherm Medical AG is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Oliver Wojahn | mwb research AG |
| IGOR KIM | Oddo Seydler |
| Enid Omerovic | Oddo Seydler |